logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Min‐Hee Ryu

university of ulsan

60H-index
519Paper Count
2.0WCitation Count
Published Papers 164
Publication Date
logo
Association between the presence of malignant ascites and survival outcomes in gastric cancer patients treated with nivolumab plus chemotherapy
errInternational Journal of Cancer
IF4.7
err2026-01-28
err0
PREAI
errYuna Lee; Hyung-Don Kim; Hyungeun Lee; Jaewon Hyung; Meesun Moon; Jungeun Ma; Min-Hee Ryu
errShare
errSave
Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer
errGastric Cancer
IF5.1
err2026-01-03
err0
PREAI
errSeong-Eun Kim; Hyung-Don Kim; Meesun Moon; Jaewon Hyung; Jungeun Ma; Hyungeun Lee; Min-Hee Ryu
errShare
errSave
Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer
errBritish Journal of Cancer
IF6.8
err2025-11-11
err0
PREAI
errKeun-Wook Lee; Dae Young Zang; Hyung-Don Kim; Jin-Won Kim; Bum Jun Kim; Yoon-Koo Kang; Min-Hee Ryu; Hark Kyun Kim
errShare
errSave
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial
errEuropean Journal of Cancer
IF7.1
err2025-09-20
err0
PREAI
errMaeve A. Lowery; Lucjan S. Wyrwicz; Do-Youn Oh; Kai-Keen Shiu; Patricio Yañez; Yuxian Bai; Min-Hee Ryu; Jeeyun Lee; Fernando Rivera; Gustavo Vasconcelos Alves; Marcelo Garrido; Manuel González Fernández; Jin Li; Timuçin Çil; Felipe Melo Cruz; Shukui Qin; Yanfen Guan; Adriana Valderrama; Sonal Bordia; Sun Young Rha
errShare
errSave
Predictive value of homologous recombination-related gene mutations in survival outcomes of first-line nivolumab plus chemotherapy for gastric cancer
errGastric Cancer
IF5.1
err2025-07-28
err0
PREAI
errYuna Lee; Hyung-Don Kim; Sun Young Lee; Hyungeun Lee; Jaewon Hyung; Meesun Moon; Jinho Shin; Young Soo Park; Tae Won Kim; Min-Hee Ryu
errShare
errSave
Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer
errBritish Journal of Cancer
IF6.8
err2025-06-20
err0
PREAI
errKeun-Wook Lee; Da Young Zang; Hyung-Don Kim; Jin-Won Kim; Bum Jun Kim; Yoon-Koo Kang; Min-Hee Ryu; Hark Kyun Kim
errShare
errSave
Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer
errBRITISH JOURNAL OF CANCER
IF6.8
err2025-05-21
err0
PREAI
errLee, Keun Wook; Zang, Da Young; Kim, Hyung-Don; Kim, Jin-Won; Kim, Bum Jun; Kang, Yoon-Koo; Ryu, Min-Hee; Kim, Hark Kyun
errShare
errSave
Predictive value of EBV-positivity in patients with gastric cancer treated with first-line nivolumab plus chemotherapy
errGASTRIC CANCER
IF5.1
err2025-04-28
err0
PREAI
errHyung-Don Kim; So-Yeon Kim; Hyungeun Lee; Yuna Lee; Jaewon Hyung; Meesun Moon; Jinho Shin; Young Soo Park; Min-Hee Ryu
errShare
errSave
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
errJournal of Hepatology
IF33
err2025-04-11
err0
errOAAI
errLorenza Rimassa; Stephen L. Chan; Bruno Sangro; George Lau; Masatoshi Kudo; Maria Reig; Valeriy Breder; Min-Hee Ryu; Yuriy Ostapenko; Wattana Sukeepaisarnjaroen; Maria Varela; David Tougeron; Oxana V. Crysler; Mohamed Bouattour; Tu Van Dao; Vincent C. Tam; Adilson Faccio; Junji Furuse; Long-Bin Jeng; Yoon Koo Kang; Robin K. Kelley; Michael J. Paskow; Di Ran; Ioannis Xynos; John F. Kurland; Alejandra Negro; Ghassan K. Abou-Alfa
errShare
errSave
Low positivity rate of fibroblast growth factor receptor 2b is associated with heterogeneous expression in gastric cancer
errGASTRIC CANCER
IF5.1
err2025-04-11
err0
PREAI
errLee, Heonwoo; Ryu, Min-Hee; Lee, In-Seob; Ahn, Ji Yong; Lee, Jeong Hoon; Lee, Hyungeun; Kim, Hyung-Don; Park, Young Soo
errShare
errSave
Updated efficacy and safety of SHR-A1811, an anti-HER2 antibody-drug conjugate, in heavily pretreated advanced solid tumors with HER2-expression or mutations: a global, multicenter, phase 1 study
errBREAST
IF7.9
err2025-02-01
err0
errOAAI
errYao, H.; Yan, M.; Tong, Z.; Wu, X.; Yin, Y.; Ryu, M. -h.; Park, J. J.; Dai, T.; Zhao, Y.; Kim, J. H.; Wang, S.; Zhong, Y.; Voskoboynik, M.; Zhang, J.; Kaubisch, A.; Liu, C.; Chen, Y.; Im, S. -a.; Wu, L.; Liu, Y.; Ganju, V.; Barve, M.; Li, H.; Yao, G.; Bao, L.; Teng, Y.; Qian, J.; Zhou, H.; Zhao, J.; Zhao, K.; Shen, Y.; Rong, S.; Zhu, X.; Song, E.
errShare
errSave
Advancing Systemic Therapy in Gastric Cancer: Key Updates From the Korean Practice Guidelines for Gastric Cancer 2024
errgastric cancer
IF3.8
err2025-01-01
err0
PREAI
errRyu, Min-Hee; Ryu, Keun Won
errShare
errSave
KEYNOTE-859 update: Pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errRyu, M. H.; Rha, S. Y.; Wyrwicz, L. S.; Weber, P. E. Yanez; Bai, Y.; Lee, J.; Herrero, F. Rivera; Alves, G. V.; Garrido, M.; Shiu, K-K.; Gonzalez Fernandez, M.; Li, J.; Lowery, M. A.; Cil, T.; Cruz, F.; Oh, D-Y.; Yin, L.; Bordia, S.; Bhagia, P.; Qin, S.
errShare
errSave
Survival outcomes of patients with gastric cancer treated with first-line nivolumab plus chemotherapy based on claudin 18.2 expression
errGASTRIC CANCER
IF5.1
err2024-11-11
err0
PREAI
errKim, Hyung-Don; Shin, Jinho; Hyung, Jaewon; Lee, Hyungeun; Moon, Meesun; Ma, Jeongeun; Park, Young Soo; Ryu, Min-Hee
errShare
errSave
Impact of systemic steroids on the efficacy of first line imatinib treatment of patients with advanced gastrointestinal stromal tumors (GISTs)
errBMC CANCER
IF3.4
err2024-10-08
err0
errOAAI
errKim, Sejin; Kim, Hyung-Don; Kim, Eo Jin; Ryu, Min-Hee; Kang, Yoon-Koo
errShare
errSave
Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific
errTARGETED ONCOLOGY
IF4
err2024-10-03
err0
PREAI
errKim, Sejin; Lee, Suat Ying; Cheon, Jaekyung; Kim, Hyung-Don; Park, Young Gyu; Lee, Joycelyn Jie Xin; Ryu, Min-Hee; Ryoo, Baek-Yeol; Tai, David; Yoo, Changhoon
errShare
errSave
Phase I/Ib open-label study of an HER2-targeted T cell engager (TCE)-SAR443216 in patients (pts) with advanced solid tumors: Intravenous (IV) dose-escalation results
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errMoreno Garcia, V.; Oh, D-Y.; Ryu, M. H.; Calvo, E.; Garralda, E.; Chung, W-P.; Bai, L-Y.; Rojas Laimito, K. I.; Yildirim, O.; Masciari, S.; Mi, G.; Wang, L.; Kanlikilicer, P.; Buday, B.; Rharbaoui, F.; Abbadessa, G.; Dumbrava, E. E.
errShare
errSave
Fostrox (fostroxacitabine bralpamide) plus lenvatinib in patients with locally advanced unresectable or metastatic hepatocellular carcinoma (HCC) progressed on immunotherapy combinations: Results from a multi-center phase Ib/IIa study
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errChon, H.; Heo, J.; Evans, T. R. J.; Kim, D. Y.; Lim, H. Y.; Macarulla Mercade, T.; Gomez Martin, C.; Moreno Garcia, V.; Ryu, M. H.; Baumann, P.; Bhoi, S.; Jensen, M.; Tunblad, K.; Wallberg, H.; Oberg, F. G.; Reig Monzon, M. E.
errShare
errSave
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial
errGASTRIC CANCER
IF5.1
err2024-08-20
err1
errOAAI
errBoku, Narikazu; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Yamaguchi, Kensei; Kato, Ken; Kadowaki, Shigenori; Tsuji, Kunihiro; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Chung, Ik-Joo; Sym, Sun Jin; Chen, Li-Tzong; Chen, Jen-Shi; Bai, Li-Yuan; Nakada, Takashi; Hagihara, Shunsuke; Makino, Reina; Nishiyama, Eiji; Kang, Yoon-Koo
errShare
errSave
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
errSCIENTIFIC REPORTS
IF3.9
err2024-07-31
err9
errOAAI
errChoi, Eugene; Shin, Jinho; Ryu, Min-Hee; Kim, Hyung-Don; Park, Young Soo
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Gad Getz
H-index: 248 · Papers: 1.8K
E
Eric Van Cutsem
H-index: 174 · Papers: 1.8K
J
Jaffer A. Ajani
H-index: 152 · Papers: 1.7K
J
Josep Tabernero
H-index: 146 · Papers: 2.7K
A
Andrew D. Cherniack
H-index: 120 · Papers: 1.1K
View more